Journal of Gastroenterology

, Volume 47, Issue 11, pp 1165–1176

Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics

Review

Abstract

Perihilar cholangiocarcinomas are defined anatomically as “tumors that are located in the extrahepatic biliary tree proximal to the origin of the cystic duct”. However, as the boundary between the extrahepatic and intrahepatic bile ducts is not well defined, perihilar cholangiocarcinomas potentially include two types of tumors: one is the “extrahepatic” type, which arises from the large hilar bile duct, and the other is the “intrahepatic” type, which has an intrahepatic component with the invasion of the hepatic hilus. The new TNM staging system published by the International Union Against Cancer (UICC) has been well revised with regard to perihilar cholangiocarcinoma, but it still lacks stratification of patient prognosis and has little applicability for assessing the feasibility of surgical treatment; therefore, further refinement is essential. Most patients with perihilar cholangiocarcinomas present with jaundice, and preoperative biliary drainage is mandatory. Previously, percutaneous transhepatic biliary drainage was used in many centers; however, it is accepted that endoscopic naso-biliary drainage is the most suitable method of preoperative drainage. Portal vein embolization is now widely used as a presurgical treatment for patients undergoing an extended hepatectomy to minimize postoperative liver dysfunction. The surgical resection of a perihilar cholangiocarcinoma is technically demanding and continues to be the most difficult challenge for hepatobiliary surgeons. Because of advances in diagnostic and surgical techniques, surgical outcomes and survival rates after resection have steadily improved. However, survival, especially for patients with lymph node metastasis, is still unsatisfactory, and the establishment of adjuvant chemotherapy is necessary. Further synergy of endoscopists, radiologists, oncologists, and surgeons is required to conquer this intractable disease.

Keywords

Perihilar cholangiocarcinoma Definition Staging Surgery 

References

  1. 1.
    International Union Against Cancer (UICC). TNM classification of malignant tumors. 7th ed. New York: Wiley-Liss; 2009.Google Scholar
  2. 2.
    DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumor. Ann Surg. 1996;224:463–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–19.PubMedCrossRefGoogle Scholar
  5. 5.
    Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–17.PubMedCrossRefGoogle Scholar
  6. 6.
    Capussotti L, Muratore A, Polastri R, Ferrero A, Massucco P. Liver resection for hilar cholangiocarcinoma: in hospital mortality and long-term survival. J Am Coll Surg. 2002;195:641–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg. 2002;6:617–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73–83.PubMedGoogle Scholar
  9. 9.
    Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84–92.PubMedGoogle Scholar
  10. 10.
    IJitsma A, Appeltans B, deJong K, Porte R, Peeters P, Slooff M, et al. Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg. 2004;8:686–94.PubMedCrossRefGoogle Scholar
  11. 11.
    Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95–101.PubMedCrossRefGoogle Scholar
  12. 12.
    Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693–702.PubMedCrossRefGoogle Scholar
  13. 13.
    Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery. 2007;141:581–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asian experiences. J Hepatobiliary Pancreat Surg. 2010;17:476–89.CrossRefGoogle Scholar
  16. 16.
    van Gulik TM, Kloek JJ, Ruys AT, Busch ORC, van Tienhoven GJ, Lameris JS, et al. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol. 2011;37:65–71.PubMedCrossRefGoogle Scholar
  17. 17.
    Young AL, Igami T, Senda Y, Adair R, Farid S, Toogood G, et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western center demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB. 2011;13:483–93.PubMedCrossRefGoogle Scholar
  18. 18.
    Saxena A, Chua T, Chu F, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202:310–20.PubMedCrossRefGoogle Scholar
  19. 19.
    Cannon R, Brock G, Buell JF. Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB. 2012;14:142–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535–44.PubMedCrossRefGoogle Scholar
  21. 21.
    Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, et al. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg. 1991;78:727–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology. 1991;38:170–5.PubMedGoogle Scholar
  23. 23.
    Sakamoto E, Nimura Y, Hayakawa N, Kamiya S, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998;227:405–11.PubMedCrossRefGoogle Scholar
  24. 24.
    Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385–92.PubMedCrossRefGoogle Scholar
  25. 25.
    Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y. Anatomic right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg. 2006;243:28–32.PubMedCrossRefGoogle Scholar
  27. 27.
    Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg. 2007;246:1052–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009;249:296–302.PubMedCrossRefGoogle Scholar
  29. 29.
    Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115–23.PubMedCrossRefGoogle Scholar
  30. 30.
    Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, et al. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg. 2012;255:754–62.PubMedCrossRefGoogle Scholar
  31. 31.
    Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.Google Scholar
  32. 32.
    Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single center 34-year review of 574 consecutive resections. Ann Surg. 2012 (in press).Google Scholar
  33. 33.
    Nakanuma Y, Curado MP, Franceschi S, Gores G, Paradis V, Sripa B, et al. Intrahepatic cholangiocarcinoma. WHO classification of tumor of the digestive system. 4th ed. Lyon: IARC; 2010.Google Scholar
  34. 34.
    Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am J Med. 1965;38:241–56.PubMedCrossRefGoogle Scholar
  35. 35.
    Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer. 1977;39:232–46.PubMedCrossRefGoogle Scholar
  36. 36.
    Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer. 1995;76:2449–56.PubMedCrossRefGoogle Scholar
  37. 37.
    Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M. The concept of perihilar cholangiocarcinoma is valid. Br J Surg. 2009;96:926–34.PubMedCrossRefGoogle Scholar
  38. 38.
    Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512–22.PubMedCrossRefGoogle Scholar
  39. 39.
    International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss; 2002.Google Scholar
  40. 40.
    Patel T. Cholangiocarcinoma—controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011;8:189–200.PubMedCrossRefGoogle Scholar
  41. 41.
    Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2012 (in press).Google Scholar
  42. 42.
    Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–6.PubMedGoogle Scholar
  43. 43.
    Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215:31–8.PubMedCrossRefGoogle Scholar
  44. 44.
    DeOliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363–71.PubMedCrossRefGoogle Scholar
  45. 45.
    Nagino M. Perihilar cholangiocarcinoma: a much needed but imperfect new staging system. Nat Rev Gastroenterol Hepatol. 2011;8:252–3.PubMedGoogle Scholar
  46. 46.
    Nishio H, Nagino M, Nimura Y. Value of percutaneous transhepatic portography before hepatectomy for hilar cholangiocarcinoma. Br J Surg. 1999;86:1415–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006;239:113–21.PubMedCrossRefGoogle Scholar
  48. 48.
    Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. AM J Surg. 2007;193:702–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Okumoto T, Sato A, Yamada T, Takase K, Matsuhashi T, Tsuda M, et al. Correct diagnosis of vascular encasement and longitudinal extension of hilar cholangiocarcinoma by four-channel multidetector-row computed tomography. Tohoku J Exp Med. 2009;217:1–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Sugiura T, Nishio H, Nagino M, Senda Y, Ebata T, Yokoyama Y, et al. Value of multidetector-row computed tomography in diagnosis of portal vein invasion by perihilar cholangiocarcinoma. World J Surg. 2008;32:1478–84.PubMedCrossRefGoogle Scholar
  51. 51.
    Fukami Y, Ebata T, Yokoyama Y, Igami G, Sugawara G, Takahashi Y, et al. Diagnostic ability of MDCT to assess right hepatic artery invasion by perihilar cholangiocarcinoma with left-sided predominance. J Hepatobiliary Pancreat Sci. 2012;19:179–86.PubMedCrossRefGoogle Scholar
  52. 52.
    Yoshioka Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. “Supraportal” right hepatic artery: an anatomic trap in hepatobiliary and transplant surgery. World J Surg. 2011;35:1340–4.PubMedCrossRefGoogle Scholar
  53. 53.
    Senda Y, Nishio H, Oda K, Yokoyama Y, Ebata T, Igami T, et al. Value of multidetector-row CT in the assessment of longitudinal extension of cholangiocarcinoma: correlation between MDCT and microscopic findings. World J Surg. 2009;33:1459–67.PubMedCrossRefGoogle Scholar
  54. 54.
    Noji T, Kondo S, Hirano S, Tanaka E, Suzuki O, Shichinohe T. Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg. 2008;95:92–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Vilgrain V. Staging cholangiocarcinoma by imaging studies. HPB. 2008;10:106–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with 18F fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology. 2001;33:1029–35.PubMedCrossRefGoogle Scholar
  57. 57.
    Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, et al. Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging. 2002;29:1047–54.PubMedCrossRefGoogle Scholar
  58. 58.
    Lee SW, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol. 2010;45:560–6.PubMedCrossRefGoogle Scholar
  59. 59.
    Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145–51.PubMedCrossRefGoogle Scholar
  60. 60.
    Nimura Y, Shionoya S, Hayakawa N, Kamiya J, Kondo S, Yasui A. Value of percutaneous transhepatic cholangioscopy (PTCS). Surg Endosc. 1988;2:213–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy. 1993;25:76–80.PubMedCrossRefGoogle Scholar
  62. 62.
    De Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L, et al. Tissue sampling at ERCP in suspected malignant biliary stricture (Part 1). Gastrointest Endosc. 2002;56:552–61.PubMedCrossRefGoogle Scholar
  63. 63.
    De Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L, et al. Tissue sampling at ERCP in suspected malignant biliary stricture (Part 2). Gastrointest Endosc. 2002;56:720–30.PubMedCrossRefGoogle Scholar
  64. 64.
    Kawashima H, Itoh A, Ohno E, Gotoh H, Hirooka Y. Transpapillary biliary forceps biopsy to distinguish benign biliary stricture form malignancy: how many tissue samples should be obtained? Dig Endosc. 2012;24:22–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005;62:374–82.PubMedCrossRefGoogle Scholar
  66. 66.
    Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging. Gastrointest Endosc. 2007;66:730–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Takada T, Hanyu F, Kobayashi S, Uchida Y. Percutaneous transhepatic cholangial drainage: direct approach under fluoroscopic control. J Surg Oncol. 1976;8:83–97.PubMedCrossRefGoogle Scholar
  68. 68.
    Nagino M, Hayakawa N, Nimura Y, Dohke M, Kitagawa S. Percutaneous transhepatic biliary drainage in patients with malignant biliary obstruction of the hepatic confluence. Hepatogastroenterology. 1992;39:296–300.PubMedGoogle Scholar
  69. 69.
    Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M. Technique of inserting multiple biliary drains and management. Hepatogastroenterology. 1992;42:323–31.Google Scholar
  70. 70.
    Maguchi H, Takahashi K, Katanuma A, Osanai M, Nakahara K, Matuzaki S, et al. Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007;14:441–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Arakura N, Takayama M, Ozaki Y, Maruyama M, Chou Y, Kodama R, et al. Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2009;16:473–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Kawakami H, Kuwatani M, Onodera M, Haba S, Eto K, Ehira N, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol. 2011;46:242–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Kawashima H, Itoh A, Ohno E, Itoh Y, Ebata T, Nagino M, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg. 2012 (in press).Google Scholar
  74. 74.
    Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010;97:1860–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Hwang S, Song GW, Ha TY, Lee YJ, Kim KH, Ahn CS, et al. Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer. World J Surg. 2012;36:379–85.PubMedCrossRefGoogle Scholar
  76. 76.
    Kanai M, Nimura Y, Kamiya J, Kondo S, Nagino M, Miyachi M, et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery. 1996;119:498–504.PubMedCrossRefGoogle Scholar
  77. 77.
    Liu CL, Lo CM, Lai EC, Fan ST. Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg. 1998;133:293–6.PubMedCrossRefGoogle Scholar
  78. 78.
    Gerhards MF, den Hartog D, Rauws EA, van Gulik TM, Gonzalez D, Lameris JS, et al. Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma. Eur J Surg. 2001;167:274–80.PubMedCrossRefGoogle Scholar
  79. 79.
    Vibert E, Farges O, Regimbeau JM, Belghiti J. Benign hilar biliary strictures stented with metallic stents can be resected by using an oncologic approach. Surgery. 2005;137:506–10.PubMedCrossRefGoogle Scholar
  80. 80.
    Lytras D, Olde Damink SW, Amin Z, Imber CJ, Malago M, et al. Radical surgery in the presence of biliary metallic stents: revising the palliative scenario. J Gastrointest Surg. 2011;15:489–95.PubMedCrossRefGoogle Scholar
  81. 81.
    Makuuchi M, Takayasu K, Takuma T, Yamazaki S, Hasegawa H, Nishiura S, et al. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. J Jpn Soc Clin Surg. 1984;45:14–20. (in Japanese).Google Scholar
  82. 82.
    Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.PubMedGoogle Scholar
  83. 83.
    Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;244:524–35.Google Scholar
  85. 85.
    Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M. Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg. 2012;29:23–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29:1099–105.PubMedCrossRefGoogle Scholar
  87. 87.
    Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81.PubMedGoogle Scholar
  88. 88.
    Nagino M, Nimura Y, Hayakawa N. Percutaneous transhepatic portal embolization using newly devised catheters. World J Surg. 1993;17:520–4.PubMedCrossRefGoogle Scholar
  89. 89.
    Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996;200:559–63.PubMedGoogle Scholar
  90. 90.
    Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery. 1995;117:677–81.PubMedCrossRefGoogle Scholar
  91. 91.
    Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery. 2000;127:155–60.PubMedCrossRefGoogle Scholar
  92. 92.
    Nagino M, Kanai M, Morioka A, Yamamoto H, Kawabata Y, Hayakawa N, et al. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol. 2000;11:1063–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract carcinoma patients after right portal vein embolization. Hepatology. 1995;21:434–9.PubMedGoogle Scholar
  94. 94.
    Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization; an appraisal by biliary indocyanine green excretion. Ann Surg. 1996;223:77–83.PubMedCrossRefGoogle Scholar
  95. 95.
    Goto Y, Nagino M, Nimura Y. Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann Surg. 1998;228:209–13.PubMedCrossRefGoogle Scholar
  96. 96.
    Nagino M, Nimura Y, Kamiya J, Kanai M, Hayakawa N, Yamamoto H. Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. Am J Roentgenol. 1998;171:1037–9.CrossRefGoogle Scholar
  97. 97.
    Kito Y, Nagino M, Nimura Y. Doppler evaluation of hepatic arterial blood flow velocity after percutaneous transhepatic portal vein embolization. Am J Roentgenol. 2001;176:909–12.CrossRefGoogle Scholar
  98. 98.
    Madoff DC, Makuuchi M, Nagino M, Vauthey JN, editors. Venous embolization of the liver. Springer, London, 2011.Google Scholar
  99. 99.
    Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005;16:215–25.PubMedCrossRefGoogle Scholar
  100. 100.
    de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, et al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol. 2010;17:2081–9.PubMedCrossRefGoogle Scholar
  101. 101.
    Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165–75.PubMedCrossRefGoogle Scholar
  102. 102.
    Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208–17.PubMedGoogle Scholar
  103. 103.
    Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg. 2000;135:302–8.PubMedCrossRefGoogle Scholar
  104. 104.
    Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260–8.PubMedCrossRefGoogle Scholar
  105. 105.
    Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, et al. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg. 2010;251:281–6.PubMedCrossRefGoogle Scholar
  106. 106.
    Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, et al. Oncologic superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19:1602–8.PubMedCrossRefGoogle Scholar
  107. 107.
    Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K. No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg. 2009;16:502–7.PubMedCrossRefGoogle Scholar
  108. 108.
    Ota T, Araida T, Yamamoto M, Takasaki K. Operative outcome and problems of right hepatic lobectomy with pancreatoduodenectomy for advanced carcinoma of the biliary tract. J Hepatobiliary Pancreat Surg. 2007;14:155–8.PubMedCrossRefGoogle Scholar
  109. 109.
    Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787–94.PubMedCrossRefGoogle Scholar
  110. 110.
    Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, et al. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg. 2008;196:160–9.PubMedCrossRefGoogle Scholar
  111. 111.
    Sakamoto Y, Sano T, Shimada K, Kosuge T, Kimata Y, Sakuraba M, et al. Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbeck’s Arch Surg. 2006;391:203–8.CrossRefGoogle Scholar
  112. 112.
    Yamanaka N, Yasui C, Yamanaka J, Ando T, Kuroda N, Maeda S, et al. Left hemihepatectomy with microsurgical reconstruction of the right-sided hepatic vasculature: a strategy for preserving hepatic function in patients with proximal bile duct cancer. Langenbeck’s Arch Surg. 2001;386:364–8.CrossRefGoogle Scholar
  113. 113.
    Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, et al. Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg. 2003;27:1137–42.PubMedCrossRefGoogle Scholar
  114. 114.
    Takasaki K, Kobayashi S, Mutoh H, Akimoto S, Toda I, Asado S, et al. Our experiences (5 cases) of extended right lobectomy combined with pancreato-duodenectomy for the carcinoma of the gall bladder (in Japanese). Tan to Sui. 1980;1:923–32.Google Scholar
  115. 115.
    Tsukada K, Yoshida K, Aono T, Koyama S, Shirai Y, Uchida K, et al. Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg. 1994;81:108–10.PubMedCrossRefGoogle Scholar
  116. 116.
    Kaneoka Y, Yamaguchi A, Isogai M, Kumda T. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg. 2010;34:2662–70.PubMedCrossRefGoogle Scholar
  117. 117.
    Hemming AW, Magliocca JF, Fujita S, Kayler LK, Hochwald S, Zendejas I, et al. Combined resection of the liver and pancreas for malignancy. J Am Coll Surg. 2010;210:808–16.PubMedCrossRefGoogle Scholar
  118. 118.
    Miwa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, et al. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy? J Hepatobiliary Pancreat Surg. 2007;14:136–41.PubMedCrossRefGoogle Scholar
  119. 119.
    Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010;23:692–7.PubMedCrossRefGoogle Scholar
  120. 120.
    Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreatobiliary carcinoma. Cancer. 2002;95:1685–95.PubMedCrossRefGoogle Scholar
  121. 121.
    Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S, et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2006;57:647–53.PubMedCrossRefGoogle Scholar
  122. 122.
    Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GEMOX study. Ann Oncol. 2004;15:1339–43.PubMedCrossRefGoogle Scholar
  123. 123.
    Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA, et al. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer. 2004;101:578–86.PubMedCrossRefGoogle Scholar
  124. 124.
    Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer. 2004;91:1769–74.PubMedCrossRefGoogle Scholar
  125. 125.
    Valle J, Wasan H, Palner DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–81.PubMedCrossRefGoogle Scholar
  126. 126.
    Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010;103:469–74.PubMedCrossRefGoogle Scholar
  127. 127.
    Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, et al. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg. 2009;250:950–6.PubMedCrossRefGoogle Scholar
  128. 128.
    Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, et al. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009;13:1470–9.PubMedCrossRefGoogle Scholar
  129. 129.
    Kobayashi H, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, et al. Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection. Ann Surg. 2012;256:288–96.Google Scholar
  130. 130.
    Igami T, Nishio H, Ebata T, Yokoyama Y, Sugawara G, Nimura Y, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010;17:449–54.PubMedCrossRefGoogle Scholar
  131. 131.
    Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010;17:455–62.PubMedCrossRefGoogle Scholar
  132. 132.
    Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, et al. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463–9.PubMedCrossRefGoogle Scholar
  133. 133.
    Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, et al. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci. 2010;17:470–5.PubMedCrossRefGoogle Scholar
  134. 134.
    Young AL, Prasad KR, Toogood GJ, Lodge PA. Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci. 2010;17:497–504.PubMedCrossRefGoogle Scholar
  135. 135.
    Rocha FG, Matsuo K, Blumgart LH, Jarnagin WR. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci. 2010;17:490–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2012

Authors and Affiliations

  1. 1.Division of Surgical Oncology, Department of SurgeryNagoya University Graduate School of MedicineNagoyaJapan

Personalised recommendations